30 related articles for article (PubMed ID: 8021588)
1. Study of Dengue virus infection in SCID mice engrafted with human K562 cells.
Lin YL; Liao CL; Chen LK; Yeh CT; Liu CI; Ma SH; Huang YY; Huang YL; Kao CL; King CC
J Virol; 1998 Dec; 72(12):9729-37. PubMed ID: 9811707
[TBL] [Abstract][Full Text] [Related]
2. Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype.
Smith KM; Nanda K; Spears CJ; Ribeiro M; Vancini R; Piper A; Thomas GS; Thomas ME; Brown DT; Hernandez R
Virol J; 2011 Jun; 8():289. PubMed ID: 21658241
[TBL] [Abstract][Full Text] [Related]
3. Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines.
Pérez-Vélez ME; García-Nieves T; Colón-Sánchez C; Martínez I
P R Health Sci J; 2009 Sep; 28(3):239-50. PubMed ID: 19715116
[TBL] [Abstract][Full Text] [Related]
4. Dengue virus type 3, South Pacific Islands, 2013.
Cao-Lormeau VM; Roche C; Musso D; Mallet HP; Dalipanda T; Dofai A; Nogareda F; Nilles EJ; Aaskov J
Emerg Infect Dis; 2014 Jun; 20(6):1034-6. PubMed ID: 24856252
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of dengue virus binding proteins in Aedes aegypti mosquitoes and Aedes albopictus cells.
Muñoz Mde L; Limón-Camacho G; Tovar R; Diaz-Badillo A; Mendoza-Hernández G; Black WC
Biomed Res Int; 2013; 2013():875958. PubMed ID: 24324976
[TBL] [Abstract][Full Text] [Related]
6. C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins.
Tsai WY; Hsieh SC; Lai CY; Lin HE; Nerurkar VR; Wang WK
PLoS One; 2012; 7(12):e52600. PubMed ID: 23300717
[TBL] [Abstract][Full Text] [Related]
7. The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.
Coller BA; Clements DE; Bett AJ; Sagar SL; Ter Meulen JH
Vaccine; 2011 Sep; 29(42):7267-75. PubMed ID: 21777637
[TBL] [Abstract][Full Text] [Related]
8. A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.
Faheem M; Raheel U; Riaz MN; Kanwal N; Javed F; us Sahar Sadaf Zaidi N; Qadri I
Mol Biol Rep; 2011 Aug; 38(6):3731-40. PubMed ID: 21107723
[TBL] [Abstract][Full Text] [Related]
9. An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes.
Khanam S; Rajendra P; Khanna N; Swaminathan S
BMC Biotechnol; 2007 Feb; 7():10. PubMed ID: 17302980
[TBL] [Abstract][Full Text] [Related]
10. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
Oliphant T; Engle M; Nybakken GE; Doane C; Johnson S; Huang L; Gorlatov S; Mehlhop E; Marri A; Chung KM; Ebel GD; Kramer LD; Fremont DH; Diamond MS
Nat Med; 2005 May; 11(5):522-30. PubMed ID: 15852016
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay.
Cuzzubbo AJ; Endy TP; Nisalak A; Kalayanarooj S; Vaughn DW; Ogata SA; Clements DE; Devine PL
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1150-5. PubMed ID: 11687456
[TBL] [Abstract][Full Text] [Related]
12. Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus.
Rothman AL; Kurane I; Ennis FA
J Virol; 1996 Oct; 70(10):6540-6. PubMed ID: 8794288
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form.
Allison SL; Stadler K; Mandl CW; Kunz C; Heinz FX
J Virol; 1995 Sep; 69(9):5816-20. PubMed ID: 7637027
[TBL] [Abstract][Full Text] [Related]
14. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice.
Delenda C; Staropoli I; Frenkiel MP; Cabanié L; Deubel V
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1569-78. PubMed ID: 8021588
[TBL] [Abstract][Full Text] [Related]
15. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.
Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C
Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710
[TBL] [Abstract][Full Text] [Related]
16. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses.
Deubel V; Bordier M; Megret F; Gentry MK; Schlesinger JJ; Girard M
Virology; 1991 Jan; 180(1):442-7. PubMed ID: 1984665
[TBL] [Abstract][Full Text] [Related]
17. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.
Delenda C; Frenkiel MP; Deubel V
Arch Virol; 1994; 139(1-2):197-207. PubMed ID: 7826210
[TBL] [Abstract][Full Text] [Related]
18. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
